LAMISIL (TERBINAFINE HYDROCHLORIDE) — FDA Approval NDA020192 (NOVARTIS)
LAMISIL (TERBINAFINE HYDROCHLORIDE) — FDA Approval NDA020192 (NOVARTIS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LAMISIL; Active ingredients: TERBINAFINE HYDROCHLORIDE; Application number: NDA020192.
| Brand name | LAMISIL |
|---|---|
| Active ingredients | TERBINAFINE HYDROCHLORIDE |
| Application number | NDA020192 |
| Sponsor | NOVARTIS |
| Dosage form | CREAM |
| Route | TOPICAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19921230 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →